To estimate the impact of different food products of CREMICA on blood glucose levels in healthy individuals.
Phase 1
- Registration Number
- CTRI/2019/12/022509
- Lead Sponsor
- ATIONAL AGRI FOOD BIOTECHNOLOGY INSTITUTE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Healthy subjects (males and females) of any age.
2. Around equal ratio of males and females will be taken.
3. Subjects to be recruited will belong to the adult age group.
4. Sample size for each group for each 14 days study will be 25-30.
Exclusion Criteria
1. Subjects with gastrointestinal diseases will be excluded.
2. Patients with type 1 diabetes mellitus and cardiovascular diseases will be
excluded.
3. Heavy smokers will be excluded.
4. Heavy alcohol drinkers will be excluded.
5. Individuals on any continuous medical treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The test products are expected to have low glycemic index than the reference products. Thus blood glucose levels are expected to be modulated in the treatments (test versus reference). Below are the mentioned test products that will be administered after their reference: <br/ ><br> <br/ ><br>Timepoint: Each test product will be administered subsequently after next day of its reference product.
- Secondary Outcome Measures
Name Time Method A pattern of glycemic control of individuals and impact of eating different food on it is also expected to emerge as secondary outcome.Timepoint: Glucose reading of each individual at every 15 minute will be used for the secondary outcome.